Search
for
Sort by
Research 31–60 of 1000+
- Clinical Diagnosis of COVID-19: a Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1,757-Patient Cohort (The AndroCoV Clinical Scoring for COVID-19 Diagnosis).
- Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Long-term symptom profiles after COVID-19<i>vs</i>other acute respiratory infections: a population-based observational study (COVIDENCE UK)
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Cutaneous signs in COVID ‐19 patients: A review
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity
- Persistent Post COVID-19 Symptoms and Functional Status after 12-14 weeks of recovery, Tamil Nadu, India, 2021
- Dermatological Manifestations of COVID-19: A Brief Review
- Dermatological Manifestations of COVID-19 Patients
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study